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a b s t r a c t
Tie1 is a receptor tyrosine kinase with broad expression in embryonic endothelium. Reduction of Tie1
levels in mouse embryos with a hypomorphic Tie1 allele resulted in abnormal lymphatic patterning and
architecture, decreased lymphatic draining efﬁciency, and ultimately, embryonic demise. Here we report
that Tie1 is present uniformly throughout the lymphatics and from late embryonic/early postnatal
stages, becomes more restricted to lymphatic valve regions. To investigate later events of lymphatic
development, we employed Cre-loxP recombination utilizing a ﬂoxed Tie1 allele and an Nfatc1Cre line, to
provide loxP excision predominantly in lymphatic endothelium and developing valves. Interestingly,
unlike the early prenatal defects previously described by ubiquitous endothelial deletion, excision of Tie1
with Nfatc1Cre resulted in abnormal lymphatic defects in postnatal mice and was characterized by
agenesis of lymphatic valves and a deﬁciency of collecting lymphatic vessels. Attenuation of Tie1
signaling in lymphatic endothelium prevented initiation of lymphatic valve speciﬁcation by Prox1 high
expression lymphatic endothelial cells that is associated with the onset of turbulent ﬂow in the
lymphatic circulation. Our ﬁndings reveal a fundamental role for Tie1 signaling during lymphatic vessel
remodeling and valve morphogenesis and implicate it as a candidate gene involved in primary
lymphedema.
& 2015 Elsevier Inc. All rights reserved.
Introduction
The lymphatic vasculature is essential for the maintenance of
normal tissue ﬂuid homeostasis and for support of the immune
response. It consists of a complex network of capillaries and collect-
ing vessels. The lymphatic capillaries have discontinuous basement
membrane and loose intercellular junctions, lack of pericyte cover-
age, and are therefore highly permeable to large macromolecules. In
contrast, larger collecting lymphatic vessels are surrounded by a
substantial basement membrane and by smooth muscle cells (SMC)/
mural cells, which help to pump the lymph forward while the
luminal valves in these vessels prevent lymph backﬂow (Oliver and
Detmar, 2002). These structural features allow efﬁcient ﬂuid uptake
of protein-rich lymph from tissue interstitium by capillaries and
transport of lymph back to the blood vascular system by collecting
vessels (Tammela and Alitalo, 2010). Lymphatic vessel hypoplasia or
defective lymphatic valves can impair the ability of the lymphatic
vasculature to collect and transport ﬂuids and lead to lymphedema
(Alitalo, 2011; Schulte-Merker et al., 2011).
The mammalian lymphatic system has been shown to originate
from embryonic veins. Lymphatic vessel development starts at
embryonic day (E) 9.5 in mice. After formation of the primary
lymph sacs, primitive lymphatic capillary networks assemble by a
process of centrifugal sprouting from the lymph sacs, and then
subsequently these networks combine and remodel into a hier-
archal network of capillaries and collecting lymphatic vessels
(Koltowska et al., 2013; Tammela and Alitalo, 2010). Maturation
of collecting vessels is accompanied by the downregulation of
lymphatic marker molecules such as Lyve1, the acquisition of
partial smooth muscle cell coverage, and the formation of intra-
luminal valves (Bazigou et al., 2009; Sabine et al., 2012).
Formation of intraluminal lymphatic valves is one of the hall-
marks of the collecting lymphatic vessel characteristic of later sta-
ges of lymphatic development. Lymphatic valve formation in mice is
initiated during late embryonic development (around E16.5). It has
recently been shown that mechanical stimulus of turbulent hemo-
dynamics caused by the onset of lymph ﬂow establishes the
location, often at branch points of lymphatic vessels, where valves
develop by upregulating the expressions of Prox1 and Foxc2 (Sabine
et al., 2012). Foxc2 cooperates with Prox1 to control Connexin37
(Cx37) expression and to activate Nfatc1/Calcineurin signaling
(Sabine et al., 2012). Other molecular regulators such as Ephr-
inB2 (Makinen et al., 2005), integrin 9 and its extracellular matrix
(ECM) ligand FN-EIIIA (Bazigou et al., 2009), EMILIN1/α9β1 Integrin
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(Danussi et al., 2013), Connexin37 and Connexin43 (Kanady et al.,
2011), Bmp9 (Levet et al., 2013), and Semaphorin3a and their rece-
ptors Neuropilin1/plexin A1 (Bouvrée et al., 2012; Jurisic et al.,
2012) have been reported to be required for either lymphatic valve
formation, elongation of lymphatic valve leaﬂets, or valve matura-
tion. Despite this knowledge, the signaling mechanisms regula-
ting lymphatic remodeling and maturation, and early stages of
lymphatic-valve development are still not well understood. Impor-
tantly, although FOXC2 is induced by oscillatory shear stress in vitro
(Sabine et al., 2012), surprisingly Prox1 is not. Thus further analysis
of lymphatic endothelial cell mediators of altered hemodynamic
shear stress should provide important insights on the molec-
ular mechanisms required for the initiation of lymphatic valve
formation.
Tie1 is an orphan endothelial receptor tyrosine kinase sharing a
high degree of homology with Tie2, the receptor for the angiopoie-
tins (Peters et al., 2004; Yancopoulos et al., 2000). It is expressed
throughout both the blood and lymphatic vasculature endothelium
from early embryonic stages to the adult (Partanen et al., 1992;
Dumont et al., 1995; Qu et al., 2010) and has previously been shown
to be involved in the regulation of growth and integrity of lymphatic
capillaries (D’Amico et al., 2010; Qu et al., 2010). Accordingly, Tie1-
deﬁcient embryos have abnormal lymphatic patterning and archi-
tecture, leading to a lymphedema associated with inefﬁcient lymph
drainage and increased leakage and embryonic demise. In addition,
our laboratory has recently shown that Tie 1 is at least partially
responsible for mechanotransduction of turbulent ﬂow required for
initiation and maintenance of atherosclerotic plaque formation at the
branch points of the systemic vasculature in the adult animal (Woo
et al., 2011). Here, we report that Tie1 is expressed in developing
collecting lymphatics and becomes progressively enriched at lym-
phatic valves. We subsequently demonstrate that Tie1 is a crucial
regulator of lymphatic remodeling and valve morphogenesis by
conditional deletion of Tie1 predominantly in the lymphatic valvular
endothelium. Early post-natal animals exhibit major lymphatic
defects, including a failure to remodel their primary lymphatic
capillary plexus into a hierarchical vessel network with a deﬁnitive
collecting vessels, and lack of luminal valve formation. Furthermore,
we demonstrate that Tie1 is necessary for assembling the critical
patterned high expression of Prox1 and Foxc2 in prospective valve-
forming cells, which is required for the initiation of valve morpho-
genesis. This suggests that as previously demonstrated in the adult
systemic circulation, Tie1 may serve as a component of the mechan-
otransduction machinery required to mediate the altered hemody-
namics essential for lymphatic valve ontogeny.
Materials and methods
Mouse models
Generation of Tie1þ /lz (Puri et al., 1995) , Tie1ﬂ/ﬂ (Qu et al., 2010),
and Nfatc1Cre mice (Wu et al., 2012) has been described previously.
R26R reporter (R26fslz) mice were purchased from The Jackson
Laboratory (Bar Harbor, ME). All strains were maintained on a
mixed 129 and C57/BL6 background. The animals were handled in
accordance with institutional guidelines with the approval of the
Institutional Animal Care and Use Committee of Vanderbilt Uni-
versity School of Medicine.
Antibodies and whole-mount immunohistochemistry
Mesenteries, hearts, diaphragm, head and back skin (from
embryos), and ventral skin (from neonates) were dissected, ﬁxed
in paraformaldehyde (PFA) in phosphate-buffered saline (PBS, pH
7.4) overnight at 4 1C and then washed with PBS. Whole-mount
immunostaining was performed as described previously (Qu et al.,
2010). Brieﬂy, the samples were washed 310 min with PBST (0.1%
Tween-20 in PBS) following by 2 washes with PBTD (1% dimethyl
sulfoxide in PBST), blocked for minimum of 2 h with blocking
solution (10% serum in PBTD) and then incubated with primary
antibodies diluted in blocking solution overnight at 4 1C. At day 2,
the samples were washed for at least 4 h with PBTD and then
incubated with secondary antibodies diluted in blocking solution
overnight at 4 1C. At day 3, the samples were washed for 2–3 h with
PBTD. The following primary antibodies were used: rat anti-mouse
CD31 (Pharmingen, monoclonal MEC13.3), goat anti-mouse Vegfr3
(R&D Systems, AF743), rabbit anti-Lyve1 (Abcam, ab14917), and Cy3
conjugated anti-α-Smooth Muscle Actin (SMA) (Sigma, C-6198),
mouse anti-human Nfatc1 (Santa Cruz Biotechnology, clone 7A6),
rabbit anti-Prox1 (Abcam, ab37128), goat anti-human Prox1 (R&D
Systems, AF2727), rat anti-mouse CD105 (endoglin) (eBioscience,
14–1051), goat anti-mouse integrin-α9 (R&D Systems, AF3827),
rabbit anti-human laminin α5 (Ringelmann et al., 1999). For ﬂuor-
escence staining, Alexa Fluor 488, 594, and 647 ﬂuorochrome-
conjugated secondary antibodies (Invitrogen) were used for signal
detection. Images were acquired with a Leica TCS SP2 confocal
system (Leica Microsystems). To visualize anti-Vegfr3 staining with
light microscopy, biotinylated rabbit anti-goat IgG (Vector Labora-
tories, BA-5000) secondary antibodies were used in horseradish
peroxidase stainings with the Vectastain kit (Vector Elite PK-6100)
and DAB kit (Vector Laboratories, SK-4100).
Staining for β-galactosidase activity
Whole-mount X-gal staining was performed as previously desc-
ribed (Qu et al., 2010). Brieﬂy, whole embryos or intestine with
mesenteries were harvested in PBS, ﬁxed in 4% PFA in PBS, and then
washed three times for 15 min with a detergent rinse (2 mM MgCl2,
0.01% sodium deoxycholate, and 0.02% Nonidet P-40, in PBS). The
staining was developed in staining solution (2 mM MgCl2, 0.01%
sodium deoxycholate, and 0.02% Nonidet P-40, 5 mM potassium
ferricyanide, 5 mM potassium ferrocyanide, and X-gal 1 mg/ml, in
PBS) at 37 1C overnight. After staining, the samples were used for
histological analysis or imaged using a Leica M205 FA stereomicro-
scope and a Leica DFC310 FX digital camera (Leica Microsystems).
Quantitative RT-PCR
RNA from mesenteries of Tie1 conditional knockout (Tie1-cko)
and their control littermates at E18.5 and P1 was isolated using
TRIZOL Reagent (Invitrogen) with additional DNase treatment (Pro-
mega). cDNA was then generated using the SuperScript III Reverse
Transcriptase kit (Invitrogen). Quantitative PCR was performed on
the CFX96 TouchTM thermal cycler (Bio-Rad) using iQTM SYBR Green
Supermix (Bio-Rad). All assays were repeated at least twice, and all
samples were run in triplicate. Analysis of gene expression was
carried out using the comparative Ct (ΔΔCt) method as described by
the manufacturer. Relative quantiﬁcation of gene expression was
normalized to 18S mRNA expression level. Sequences of the PCR
primers used are listed in Supplementary Table 1.
Quantiﬁcation of lymphatic valves
Mesenteric valves were identiﬁed as areas of strongly positive
Prox1 staining and counted from duodenum to ileum. The number
of valves at each developmental stage was quantiﬁed using four
mesenteric vessels in 4 mice/genotype.
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Presentation of data and statistical analysis
Macroscopic pictures and microscopic images are representa-
tive of three or more independent experiments. Microscopic image
processing and analysis were performed using Photoshop (Adobe)
software. Data are expressed as the means7s.d. Statistical analysis
was conducted using the 2-tailed Student's t test. A P valueo0.05
was considered signiﬁcant.
Results
Tie1 expression is accentuated in developing and mature lymphatic
valves
We (Qu et al., 2010) and others (D’Amico et al., 2010) have
previously documented that Tie1 was expressed in the lymphatic
endothelial cell (LEC) progenitors and all lymphatic vessels, and that
structural capillary defects were associated with inefﬁcient lymph
drainage and lymphedema observed in hypomorphic mutant Tie1
embryos. This prompted us to examine if Tie1 might be involved in
the formation, maturation, and function of the luminal valves and
collecting-vessels. Utilizing the Tie 1 LacZ knockin/ knockout
reporter line (Puri et al., 1995), we conﬁrmed Tie1 expression in
developing collecting lymphatic vessels and developing lymphatic
valves by whole mount X-gal staining of mesenteries of hetero-
zygous Tie1þ /lz mice. Formation of lymphatic valves is initiated
around E16.0 (Bazigou and Makinen, 2013; Sabine et al., 2012). At
E16.5, Tie1 is clearly expressed in developing collecting lymphatics
although its expression level in lymphatics is lower than in either
the arteries or veins (Fig. 1A). Furthermore, regions of accentuated
Tie1 expression are detected throughout the collecting vessel. From
E17.5, X-gal (Tie1) continues to stain intensely in the arteries, and
veins, but is clearly enriched in the regions of lymphatic vessel
constriction where developing lymphatic valves will form (Fig. 1B).
Tie1 expression level in valvular endothelium persists during
subsequent maturation and is more robust in valvular endothelium
than in lymphangion cells (the segment between valves). At
postnatal day 1 (P1) (Fig. 1C) and P7 (Fig. 1D), Tie1 is highly
expressed in the leaﬂets of mature valves and this expression
proﬁle of Tie1 in mature lymphatic valves persists throughout
adulthood (Fig. 1E). Therefore, Tie1 is expressed in developing
collecting lymphatics and becomes progressively enriched at lym-
phatic valves. This expression data suggests that Tie1 might have a
role in the initiation of lymphatic valve leaﬂet development and
maintenance of the mature valve.
Nfatc1Cre mediates loxP excision in lymphatic progenitors and
endothelium of the developing lymphatic valves
To speciﬁcally determine the role of Tie1 in development of
collecting lymphatics, we utilized an Nfatc1Cre line as Nfatc1
expression has previously been shown to be accentuated in the
endothelium of the developing lymphatic valves and essential for
normal lymphatic valve development (Kulkarni et al., 2009; Norrmen
et al., 2009). In this line, a nuclear localized Cre-Recombinase is
“knocked in” to the 30 UTR of Nfatc1 preceded by an IRES (internal
bacterial ribosomal entry site) such that Cre recombinase is
expressed under control of endogenous Nfatc1 regulatory domains
without disrupting endogenous expression (Wu et al., 2012). To
characterize lymphatic expression of Cre, we analyzed Cre activity by
lacZ staining of the transgenic mice bred with R26R reporter mice. As
seen in Fig. 2(A) and (B), in addition to our previous reports on
endogenous Nfatc1 expression pattern, which is restricted to the
endocardium of developing hearts (Ranger et al., 1998; Wu et al.,
2012), we detected clear Cre activity in a subset of endothelium
within the lymph sacs and superﬁcial lymphatic vessels of the
jugular region at E12.5. Eosin stained transverse section through
the jugular region of the whole-mount X-gal staining embryo reveals
that Cre is highly active in the endothelium of the developing jugular
lymphatic sacs but not the endothelium of the cardinal veins (Fig. 2C
and D). In addition, whole-mount X-gal staining of postnatal mesen-
teries of Nfatc1Cre;R26fslzmice revealed robust expression in the early
postnatal and mature (Fig. 2E and F) lymphatic valves but not in
arteries or veins. Thus, Nfatc1Cre mediates loxP excision in lymphatic
endothelium with persistent activation in the leaﬂets of mature
luminal valves.
Agenesis of lymphatic valves in Tie1-cko mice
Conditional deletion of Tie1 in lymphatic endothelium circum-
vents early embryonic lethality seen in germ line deletion (Puri et al.,
1995; Sato et al., 1995) or hypomorphic Tie1 embryos (Qu et al.,
2010). Nfatc1Cre;Tie1ﬂ/ﬂ mice (designated as Tie1-cko mice) embryos
were indistinguishable from wild-type mice in utero and were born
at normal frequencies. However, all newborn Tie1-cko mice devel-
oped chylous ascites shortly after their initial feeding (Fig. 3B), which
was obvious by P1. The accumulation of chyle was also commonly
found in the hyper-dilated lymphatic capillaries of intestine wall
from Tie1-cko pups, but not in their normal littermates (data not
shown). Tie1þ /ﬂ, Tie1ﬂ/ﬂ, and Nfatc1Cre;Tie1þ /ﬂ pups were all normal
and showed no evidence of lymphatic defects. Chylous ascites is
characteristic of defective lymphatic function, resulting from poor
Fig. 1. Expression of Tie1 in developing and mature lymphatic valves. Whole-mount X-gal staining of mesenteric lymphatic vessels from Tie1lz/þ mice at the indicated ages
(E16.5–young adult) shows progressive enrichment of Tie1 (X-gal) at lymphatic valves. At E16.5 (A) Tie1 expression in detected developing collecting lymphatics with
accentuated expression in the region of the developing valves (Arrows). As valve development progresses (B–E), Tie1 expression becomes primarily restricted to the
lymphatic valves (arrows). a, arteries; v, veins. Scale bars, 100 μm.
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uptake and transport of chyle produced by the intestine following
feeding. This results in the leakage of lymphatic ﬂuid into the
peritoneal cavity, where it can cause an inﬂammatory response and
lead to death (Gupta et al., 2007). Consistent with generalized
lymphatic dysfunction, Tie1-cko mice demonstrate abnormal lym-
phatic pattern in internal organs similar to Tie1 hypomorphic mutant
embryos including hyper-dilated lymphatic capillaries in the intes-
tine wall and disorganized regressing or developmental retarded
Fig. 3. Chylous ascites and abnormal structure of mesenteric lymphatic vessels in Tie1-cko neonates. (A, B) A newborn Tie1-cko pup (B) compared to a Tie1þ /f littermate (A) at P2
displaying chylous ascites (arrow) in the peritoneal cavity and also frequently found in the pleural cavity (upper arrowhead). Representative macroscopic views of mesenteric
vessels in Tie1þ /f (C) and Tie1-cko (E) pups at P2. The lymphatic vessels are ﬁlled with white chyle and constrictions along the vessels reﬂect the presence of valves (arrows in
C) in control mice, but there are no such constrictions in Tie1-cko pups, even at sites of lymphatic vessel branching (arrows in E) where valve often form. Blind-ended
outcroppings of presumptive collecting vessels in Tie1-cko mice suggest leakage and regression of the developing lymphatic vessels. (D) Blood-ﬁlled mesenteric presumptive
collecting lymphatics (arrows) as well as bloody superﬁcial intestinal lymphatics (arrowheads) were observed in Tie1-cko specimen at P3. Representative neonates are
shown from 25 littermate control and 18 Tie1-cko animals examined from 9 independent litters. b, blood vessel. Scale bars: 500 μm.
Fig. 2. Nfatc1Cre mediates loxP excision in lymphatic progenitors and valve endothelium. (A) Whole-mount X-gal staining of E12.5 Nfatc1Cre;R26fslz embryo. (B) A higher
magniﬁcation view of boxed area in (A) shows X-gal positive vessels in the jugular region consistent with lymph sacs and superﬁcial lymphatic vessels (arrows).
(C) Transverse section through the jugular region of (A). (D) Boxed area in (C) is enlarged. Nfatc1 driven Cre is active in the endothelium of the developing jugular lymphatic
sacs (jls) but not the endothelium of cardinal veins (cv). Whole-mount X-gal staining of postnatal mesenteries of Nfatc1Cre;R26fslz mice at P4 (E) and 3 weeks of age
(F) reveals that the β-gal activity Cre is clearly present in leaﬂets of mature lymphatic valves (arrows) with minimal Cre mediated deletion in arteries (a) or veins (v). b, blood
vessel. lv, lymphatic vessels. Scale bars: (A) 500 μm; (D–F) 100 μm.
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lymphatic vessels at the surface of the heart and the diaphragm
(Supplementary Fig. S1). Closer examination of the chyle-ﬁlled mes-
enteric lymphatic vessels revealed that the mesenteric collecting
vessels in control neonates had characteristic constrictions reﬂecting
functional valves (Fig. 3C). In contrast, no such constrictions corre-
sponding to presumptive valve territories (even at sites of branching
and bifurcations) were visible, indicating lack of valve formation
(Fig. 3E). The presumptive collecting vessels in Tie1-cko pups were
morphologically tortuous and thinner with blind-ended outcrop-
pings, indicating regression and leakage. In addition, from P3 onward,
mesenteric presumptive collecting lymphatics and superﬁcial intest-
inal lymphatics in Tie1-cko mice began to be ﬁlled with blood
(Fig. 3D). Once this phenotype developed, demise of the Tie1-cko
pups was inevitable, occurring within one week of age.
To conﬁrm the observations of the defective lymphatic valve
phenotype in Tie1-cko mice, we visualized the lymphatic vessels by
co-immunoﬂuorescence staining with the pan-endothelial marker
CD31, the lymphatic markers (Prox1 and Vegfr3), and the markers for
lymphatic valve cells (integrin-α9 and laminin-α5) (Bazigou et al.,
2009). Expression of Prox1 or Vegfr3 is elevated in valve LECs, and
CD31 staining also highlights the valve leaﬂets. As seen in Fig. 4,
valves were abundant in the mesenteric collecting lymphatics of
control neonates, and could be visualized easily in control embryos
by wholemount co-immunostaining for Prox1 (Fig. 4 A and C) or
Vegfr3 (Fig. 4 E and G) and CD31. However, lymphatic valves were
completely absent at the corresponding sites of Tie1-cko presumptive
collecting vessels (Fig. 4B, D, F and H). Interestingly, in comparison to
control pups, Vegfr3 expression in the presumptive collecting vessels
of Tie1-cko pups (Fig. 4H) was not downregulated in the lymphan-
gion (segments between two consecutive valves) and not upregu-
lated at the presumptive valve territories as observed in the controls.
Similarly, expression of integrin-α9 (Fig. 4I–L) and laminin-α5
(Fig. 4M–P) revealed that characteristic mature valves are present
in neonatal control mesenteries but completely missing in Tie1-cko
mesenteric samples.
Attenuation of Tie1 in lymphatic endothelium prevents the initiation
of valve morphogenesis
In mice, valves originate around E16 by speciﬁcation of valve-
forming cells (Bazigou et al., 2009; Sabine et al., 2012). These cells
express high levels of Prox1 and Foxc2. Thus, the earliest sign of valve
formation is a localized upregulation of transcription factors Prox1 and
Foxc2, which is accompanied by decreased expression of Lyve1. In
Fig. 4. A deﬁciency of lymphatic valves in Tie1-cko mice. Dual whole mount immunoﬂuorescence of mesenteries from Tie1-cko pups and their Tie1þ /f littermates at P2 for
CD31 (green) and Prox1 (red, A–D), Vegfr3 (red, E-H), Integrin α9 (red, I–L), and Laminin α5 (M–P). Arrows indicate lymphatic valves as demoted by elevated expression of
Prox1, Vegfr3, integrin-α9, or Laminin α5 co-localized with CD31 in control lymphatic collecting vessels. Similar lymphatic valves were completely absent at the
corresponding sites (arrowheads) of Tie1-cko presumptisse collecting vessels. Representative images are shown from 5 control and 6 Tie1-cko pups examined from
3 independent litters in each group. b, blood vessel. Scale bars, 100 μm.
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developing collecting vessels of wild type mice, only immature
lymphatic valves are observed up to E17.5. By E18.5, lymphatic valves
at all four different stages could be found in the collecting vessels. To
determine the onset of the defective valve phenotype and the
mechanism underlying absence of valves in Tie1-cko mice, we
performed wholemount co-immunostaining of mesenteric and der-
mal lymphatics at E17.0, E17.5, and E18.5 for CD31 and Prox1. At E17.0
and E17.5, normal developing lymphatic valves at early stages (stage
Fig. 5. Attenuation of Tie1 in lymphatic endothelium prevents initiation of valve morphogenesis. Whole mount dual immunoﬂuorescence of mesenteric (A–D) or back skin (F,G)
vessels from Tie1-cko pups and their Tie1þ /f littermate controls at E17.0 with Prox1 (red) and CD31 (green, not shown in skin samples). Normal developing lymphatic valves
(arrows) at early stages were often observed in mesenteric or dermal developing collecting vessels of control embryo (A, C, and F), but only a few isolated Prox1high LEC
clusters (arrowheads) were occasionally detected in the presumptive collecting vessels of Tie1-cko embryos (B, D, and G). Representative images are shown from 5 control
and 6 Tie1-cko pups examined from 3 independent litters in each group. b, blood vessel. Scale bars, 100 μm. (E) Quantiﬁcation of the luminal valves (in Tie1-cko mice,
counted as the number of constrictions that contained clusters of cells expressing high levels of Prox1) in control and Tie1-cko embryo mesenteric lymphatic vessels at E17.5
and E18.5. Quantitative data are represented as mean and s.d. from 4 control and 4 Tie1-cko embryos examined from 3 independent litters (Po0.01). (H) RT-qPCR analysis of
control and Tie1-cko mesenteries at E18.5. Expression of 18 s was used to normalize the samples. The results are represented as mRNA fold changes measured in Tie1-cko vs.
control. Data are the mean7s.d. from 4 independent experiments performed in duplicate. n, Po0.05.
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1–3 according to Bazigou et al., 2009; Sabine et al., 2012) were often
observed in mesenteric or dermal developing collecting vessels of
control embryos (Fig. 5A, C, and F, and Supplementary Fig. S2A and C),
but only a few isolated Prox1high LEC clusters were occasionally
detected in the presumptive collecting vessels of Tie1-cko embryos
(Fig. 5B, D, G and Supplementary Fig. S2B), indicating that initiation of
lymphatic valve speciﬁcation was abnormal in the Tie1-cko embryos.
The number of constrictions that contained Prox1high LEC clusters in
Tie1-cko mesenteries at E17.5 was dramatically reduced when com-
pared to the control littermates (18.172.5 vs. 5.470.8, n¼4;
Po0.001; Fig. 5M). At E18.5, even less Prox1high LEC clusters were
observed in the mesenteric (Supplementary Fig. S2F and G and Fig. 5E)
or dermal (data not shown) developing collecting vessels of Tie1-cko
embryos. The total number of valves (stage 2–3 according to Sabine
et al., 2012) in Tie1-cko mesenteries at E18.5 was dramatically
decreased (22.173.2 vs. 2.670.6, n¼4; Po0.001; Fig. 5E). No any
fully mature lymphatic valves were detected in all Tie1-cko tissues
tested.
To identify the potential change of several key molecular reg-
ulators probably associated with lymphatic remodeling and valve
formation, we analyzed their expression in mesenteries by quanti-
tative real-time RT-PCR at E18.5 and P1. At E18.5, consistent with
the above immunoﬂuorescence staining, expression level of Prox1
and Foxc2 in Tie1-cko samples was reduced by 18.0% and 26.3%,
respectively when compared with control embryos; while expres-
sion levels of CD31, Lyve1, Vegfr3, Nfatc1, Tie2, and Ang2 had no
signiﬁcant change (Fig. 5H). In Tie1-cko neonates (P1), expression
level of Prox1 and Foxc2 was further reduced by 33.0% and 45.5%,
respectively (Supplementary Fig. S2I). Reduced expression level of
Lyve1 and Vegfr3 by 15.3% and 17.5% is in agreement with the
observation of regression of certain lymphatics in Tie1-cko mesen-
teries (data not shown and Qu et al., 2010). It should be noted that
CD31 and Tie2 are normally expressed in both blood and lymphatic
vessels, they have higher expression in blood vessels than in
lymphatics. Taken together, Tie1 is required for the initiation of
lymphatic valve development characterized by high expression of
Prox1 and Foxc2.
Lymphovenous valve formation and lymphatic-blood vessel
separation are normal in Tie1-cko embryos
Since blood-ﬁlled mesenteric lymphatics and bloody superﬁcial
intestinal lymphatics were often observed in Tie1-cko mice from P3,
this phenotype could be attributed to defects in lymphovenous valve
formation and/or lymphatic-blood vessel separation in Tie1-cko
embryos. Lymphovenous valves, which are located at the junctions
Fig. 6. Normal lymphovenous valve formation and lymphatic-blood vessel separation in Tie1-cko embryos. Sequential coronal cryosections at the junction of the internal jugular
(IJV) and subclavian (SCV) veins co-stained with Prox1 (green) and Laminin-α5 (red), or Lyve1 (red), showing the normal morphology of the left lymphovenous valves with
high expression of Prox1 and Laminin-α5 in a control (A–C) and a Tie1-cko (D–F) embryo at E13.5. The head is orientated to the top and the heart towards the bottom of the
ﬁgures. Lyve1 labels lymph sacs (LS), while Prox1 and Laminin-α5 (which is also positive in the wall of arteries) are valve speciﬁc markers. In both control and Tie1-cko mice,
the ﬁrst valve leaﬂets open into the IJV (upper arrows), while the second valve drains into the SCV/IJV junction (lower arrows). In addition, separation (with Lyve1 positive
endothelial cells) of the LS from the IJV is normal in both control (C) and Tie1-cko (F) embryos. Note the lack of blood cells within the LS in both control and Tie1-cko mice.
Representative images are shown from 5 control and 5 Tie1-cko pups examined from 3 independent litters in each group. VA, the vertebral artery. Scale bars: 100 μm.
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of the lymphatic ducts with the venous circulation, allow ﬂuid to
drain into the veins and prevent blood from entering into the
lymphatic circulation (Srinivasan and Oliver, 2011). Failure to sepa-
rate the lymphatic sacs from the veins leads to prolonged bleeding
into the lymph sacs, tortuous blood-ﬁlled cutaneous lymphatic
vessels and eventually embryonic death (Abtahian et al., 2003). As
described by Srinivasan and Oliver (2011), and Turner et al. (2014),
the lymphovenous valves form through the fusion of the lymph sacs
with the veins in a region containing a subpopulation of Prox1þ
Foxc2þ venous ECs within the internal jugular (IJV) and subclavian
(SCV) veins. As seen in Fig. 6, sequential coronal cryosections at the
junction of the IJV and SCV veins were co-stained with Prox1 (green)
and Laminin-α5 (red), or Lyve1 (red), showing the normal morphol-
ogy of the lymphovenous valves in both control (Fig. 6A–C) and Tie1-
cko (Fig. 6D–F) embryos at E13.5 and at E15.5 (Supplementary
Fig. S3). Consistent to the previous reports (Srinivasan and Oliver,
2011; Turner et al., 2014), on each of the left and right sides of both
the control and Tie1-cko embryos, two valves connecting the lymph
sacs (labeled with Lyve1) with the surrounding veins were identiﬁed.
At this location the lymph sac is split into two portions by the
vertebral artery. One of these valves is located more dorsomedially
than does the other one. The valves have high expression of the
valve-speciﬁc markers Prox1 and Laminin-α5. Furthermore, separa-
tion (with Lyve1 positive endothelial cells) of the lymph sac from the
IJV is also normal in both control (C) and Tie1-cko (F) embryos. We
detected no blood cells within the lymph sacs in both control and
Tie1-cko mice. Thus, the phenotype of blood-ﬁlled mesenteric
lymphatics in Tie1-cko neonates is not attributed to defects in
lymphovenous valve formation or lymphatic-blood vessel separation.
Attenuation of Tie1 in lymphatic endothelium prevents formation of
collecting lymphatic vessels
Because Tie1-cko mice exhibit a deﬁcit of intraluminal lymphatic
valves, we sought to determine whether there was also a deﬁciency
of collecting lymphatic vessels development. Wholemount immu-
noﬂuorescence staining of neonatal skin (P1) for Vegfr3 and Lyve1
revealed a highly branched network of lymphatic vessels in both
Tie1-cko mice and their control littermates (Fig. 7A). In control
embryos, lymphatic capillaries expressed high levels of both Vegfr3
as well as Lyve1. Collecting lymphatic vessels were identiﬁed as
vessels in which Lyve1 was downregulated but expression of Vegfr3
remained high, particularly in regions of the lymphatic valves. Thus,
both initial lymphatics with high expression of Lyve1 and Lyve1-
downregulated/Vegfr3-positive collecting lymphatic vessels are
present in the control skin as previously described (Dellinger
et al., 2008). In contrast, all lymphatic vessels throughout the
immature network of Tie1-cko skin expressed the initial lymphatic
marker Lyve1, and downregulation of Lyve1 characteristic of col-
lecting lymphatic vessel development did not occur.
To determine whether lymphatic vessels in other regions of the
body of Tie1-cko mice fail to exhibit a collecting vessel phenotype, we
examined the mesenteries of Tie1-cko mice and their control litte-
rmates at E18.5 by whole-mount immunoﬂuorescence (Fig. 7B).
Similar to observation in neonatal skin, mesenteric lymphatic vessels
of Tie1þ /f mice exhibit a mature collecting vessel phenotype, have
low expression of Lyve1 and relatively low level of Vegfr3 in the
lymphangion, and contain valves. In contrast, the comparable
mesenteric lymphatic vessels of Tie1-cko mice are immature, have
uniformly high expression of Lyve1 and Vegfr3, and lack valves
(Fig. 7B). Similarly, at E17.5, the lymphatic capillaries both in Tie1-cko
mice and in control littermates continue to express high levels of
Lyve1. However, in control embryos a relatively low level of Lyve1 in
observed in developing collecting vessels while all the lymphatics in
Tie1-cko embryos exhibit a uniformly high expression of Lyve1 (data
not shown). These data show that the failure of Tie1-cko lymphatic
vessels to exhibit an abnormal collecting vessel phenotype is not
restricted to the skin. Collectively, our data show that loss of Tie1
leads to a failure in the maturation of the primary lymphatic plexus
whole body into functional collecting lymphatic vessels.
SMCs associate with initial lymphatic vessels of Tie1-cko mice
A sparse covering by mural cells is another characteristic
feature of collecting lymphatic vessels. Normally immature col-
lecting vessels lack pericytes/SMCs, and only at later stages they
acquire sparse coverage, but the valve areas are usually devoid of
these cells (Oliver and Alitalo, 2005). To determine the potential
effect of Tie1 attenuation on the association of SMCs with dermal
lymphatic vessels, we performed wholemount immunoﬂuores-
cence staining of skin for SMA and Lyve1. Dermal lymphatic
capillaries of the control mice at E18.5, P1 and P3 lacked SMC
coverage. In contrast, SMCs were associated with about 30% of
initial lymphatic vessels in Tie1-cko mice at P3 (Fig. 8A), while this
ectopic SMC coverage occurred at a lower frequency (8%) at P1
Fig. 7. A deﬁcit of Lyve1 down-regulated collecting lymphatic vessels in Tie1-cko mice.
(A) P1 ventral skin of Tie1þ /f pups and their Tie1-cko littermates was whole-mount
co-stained for Vegfr3 (green) and Lyve1 (red). Both initial lymphatics (arrowheads)
with high expression of Lyve1 and Lyve1-down-regulated-Vegfr3-positive collect-
ing lymphatic vessels (arrow) are present in the control skin. In contrast, all
lymphatic vessels throughout the immature network of Tie1-cko skin express the
initial lymphatic marker Lyve1. (B) E18.5 mesenteries of Tie1þ/f pups (G–I) and
their Tie1-cko littermates (J–L) were whole-mount co-stained for CD31 (green) and
Lyve1 (red). Mesenteric lymphatic vessels of Tie1þ /f mice exhibit a mature
collecting vessel phenotype, have very low expression of Lyve1, and contain valves
(arrow). In contrast, the comparable mesenteric lymphatic vessels of Tie1-cko mice
are immature, have uniformly high expression of Lyve1 (arrowheads), and lack
valves. A nonlymphatic Lyve1 immunoreactivity is also observed in isolated cells
outside vessels, which probably correspond to macrophages. Representative images
are shown from at least 5 control and 5 Tie1-cko pups examined from 3 indepen-
dent litters in each group at each age. b, blood vessel. Scale bars, 100 μm.
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(Supplementary Fig. S4A–D). At E18.5, this defect was only
occasionally observed in certain severe dilated dermal lymphatic
capillaries (Supplementary Fig. S4E–H). Similarly, in the mesen-
teries of control mice at E18.5 and P3, initial lymphatic vessels
lacked SMC coverage while mural cells were only associated with
Lyve1 downregulated collecting lymphatic vessels. In contrast,
SMCs were uniformly associated with almost all lymphatic vessels
in Tie1-cko mice (Fig. 8B and Supplementary Fig. S4I–L).
Endoglin, a co-receptor for members of the transforming gro-
wth factor (TGF) superfamily, has been implicated in the recruitment
of SMCs to blood vessels (Li et al., 1999). As seen in Fig. 8C, the
mesenteric lymphatic vessels in Tie1-cko mice expressed higher
levels of endoglin than in control embryos at E18.5. Consistent with
immunoﬂuorescence staining, our qPCR revealed that endoglin
expression level in Tie1-cko mesenteries at E18.5 and at P1 is higher
than that in control samples by 25% and 22%, respectively (Fig. 5H
and Supplementary Fig. S4I).
Discussion
Previously we (Qu et al., 2010) and others (D’Amico et al., 2010)
demonstrated that mice hypomorphic for Tie1 exhibit dilated and
disorganized lymphatic vessels with impaired lymphatic drainage
capacity which resulted in embryonic demise. In the current study,
we document, for the ﬁrst time, that while Tie1 is ubiquitously
expressed at the onset of lymphatic development, there is accen-
tuated expression in LECs at the onset of lymphatic valve devel-
opment, and expression in the lymphatic system is almost exclu-
sively restricted to the endothelium of mature lymphatic valves.
Furthermore, utilizing a Cre deletor mouse line controlled by
Nfatc1 regulatory elements (Wu et. al., 2012), a transcription factor
whose activity has been shown to be essential for lymphatic valve
formation (Norrmen et al., 2009), we demonstrate that Tie1 is
necessary for lymphatic valve morphogenesis, as well as vessel
remodeling and maturation.
In preparation of this manuscript, a report by Shen et al. (2014)
also described that perturbation of Tie1 results in abnormal lympha-
tic valve development and collecting vessel remodeling further
support the results reported here. The mouse model used in their
study was homozygous mutated allele, Tie1ΔICD/ΔICD, where the put-
ative kinase domain of Tie1 was ubiquitously deleted throughout the
vasculature. In addition to defects in lymphatic valve and collecting
vessel remodeling similar to those observed in our present study, the
investigators documented earlier defects in formation of the primary
lymphatic network, which we did not observe. This is likely at least
partially the result of our use of the Nfatc1-Cre line to inactivate Tie1
in cells expressing Nfatc1, which may be more speciﬁc for lymphatic
valve cells. The phenotype observed by Shen and colleagues was
similar to that seen in the hypomorphic mouse model used in a
previous report by our group (Qu et al., 2010) and that of D’Amico
et al. (2010). In addition, we observed abnormal SMC coverage of
lymphatic vasculature (Fig. 8B and Supplementary Fig. S4) similar to
that observed in the Ang2 null mutants (Dellinger et al., 2008; Gale
et al., 2002), but this was not appreciated in the Tie1ΔICD/ΔICDmutants.
The reason for this discrepancy is uncertain.
A role for Tie1 in mechanotransduction of lymphatic ﬂow required for
valve formation
Despite the clinical importance of lymphatic valves, the molecular
mechanisms and cellular events required for the formation of
luminal valves are poorly understood and have only recently begun
to be characterized. Based on the analysis of mouse mesenteric
lymphatics (Bazigou et al., 2009; Kazenwadel et al., 2012; Koltowska
et al., 2013; Norrmén et al., 2009; Sabine et al., 2012), four different
stages of valve development have been recently deﬁned: (1) valve
initiation (formation of discrete clusters of valve-forming cells),
(2) condensation (formation of a circumferential valve territory,
alteration in cell shape and molecular identity), (3) elongation (valve
leaﬂet formation from deposition of ECM and ring-like constriction),
and (4) maturation (leaﬂet elongation and sinus formation). The
initiation of lymphatic valve development in the mouse embryos can
be ﬁrst recognized at E16, when Prox1, Foxc2 and Gata2 become
visible at high levels within discrete clusters of cells in the initial
lymphatic plexus. These cells create a clear boundary with the
neighboring lymphangion cells that express reduced levels of these
markers. Compared to controls, in mesenteric or dermal developing
collecting vessels of Tie1-cko embryos by E18.5, not only no mature
lymphatic valves were detected, but also Prox1high LEC clusters were
dramatically reduced. Thus Tie1 appears to be required for lymphatic
valve morphogenesis. Speciﬁcally, Tie1 is required for initiation of
lymphatic valve speciﬁcation.
Fig. 8. Ectopic SMCs and increased endoglin expression in lymphatics of Tie1-cko mice. (A) P3 ventral skin of Tie1þ /f pups and their Tie1-cko littermates were whole-mount
co-stained for SMA (red) and Lyve1 (green) showing that SMA positive cells are associated with Lyve1 positive initial lymphatic vessels (arrow) in Tie1-cko pups but not in
control mice. (B) E18.5 mesenteries of Tie1þ /f pups and their Tie1-cko littermates were whole-mount co-stained for SMA (red) and Vegfr3 (green). SMA positive cells are only
associated with Lyve1-down-regulated collecting lymphatic vessels in control, but with both collecting lymphatic vessels (arrowheads) and lymphatic capillaries (arrows) in
the mutants. (C) E18.5 mesenteries were whole-mount co-stained for Vegfr3 (red) and endoglin (green) showing increased lymphatic endothelial endoglin expression in
Tie1-cko embryos. Note very low level of endoglin expression at sites of lymphatic valves (arrowheads) in the control but uniformly high level at the comparable sites of Tie1-
cko embryos. Representative images are shown from at least 4 control and 5 Tie1-cko pups examined from 3 independent litters in each group at each age. Arrows indicate
lymphatic capillaries. b, blood vessel. Scale bars, 100 μm.
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Recent studies (Bazigou et al., 2009; Sabine et al., 2012) support
the hypothesis that the cooperation between lymphatic endothelial
transcription factors Foxc2 and Prox1, and mechanical forces is
essential for determining where valves ultimately form: (1) Lympha-
tic valves often form at sites of lymphatic vessel branching and
bifurcations, where lymph ﬂow may be disturbed. (2) The initiation
of valve formation in the mouse embryo coincides with the onset of
lymph ﬂow and occurs concomitantly with remodeling of a primary
lymphatic vascular plexus into functional collecting vessels. (3) Oscil-
latory but not laminar ﬂow introduced to LECs in vitro induces
expression of two crucial downstream regulators (connexin 37 and
calcineurin/Nfatc signaling) of valve morphogenesis in a Foxc2- and
Prox1-dependent manner, similar to the upregulation that precedes
valve induction in vivo. (4) Lymphatic vessels cultured ex vivo, in the
absence of ﬂuid ﬂow, lose the patterned expression of Prox1 and
Foxc2 and fail to assemble valves properly. However, to date, the
molecular pathways responsible for transducing the mechanosen-
sory signals that initiate lymphatic valve morphogenesis remain
elusive. Tie1 has recently been identiﬁed as an essential component
of the endothelial mechanosensory complex (Woo and Baldwin,
2011), and as we demonstrated here, it is highly expressed in
lymphatic-valve-forming cells and mature lymphatic valves (Fig. 1).
Moreover, Tie1 expression in the adult correlates distinctively to
vascular regions exposed to disturbed ﬂow in both physiological and
pathological conditions (Woo et al., 2011). Experiments in vivo and
in vitro revealed that Tie1 is up-regulated and activated upon
exposure of cells to disturbed ﬂow, but down-regulated by brief
application of laminar ﬂow (Chen-Konak et al., 2003; Porat et al.,
2004, Woo et al., 2011), suggesting that Tie1 mediated signaling may
be involved in regulating ﬂow-mediated responses, and thus early
stages of lymphatic valve formation. In supporting of this hypothesis,
attenuation of Tie1 abolishes Prox1 and Foxc2 upregulation in
prospective valve-forming cells of embryonic mesenteric and dermal
lymphaics.
Tie1 is required for lymphatic collecting vessel development
Tie1-cko embryos also demonstrated remodeling defects includ-
ing the failure to form mature collecting vessels. Lymphatic vessel
remodeling commences at E15.5 and continues after birth in mice.
The lymphatic vasculature develops ﬁrst as a primary capillary
plexus, and the subsequent remodeling involves sprouting of new
lymphatic capillaries from the initial plexus. In the absence of Tie1,
the early development of the dermal lymphatic vessels occurred
normally, but presumptive collecting vessels are not able to remodel
and to down-regulate the expression of lymphatic capillary markers
Lyve-1, and Vegfr3. In addition, some dilated lymphatic capillaries
particularly in skin of Tie1-cko mice acquire ectopic mural cell
coverage. Normally lymphatic capillaries are devoid of pericytes
and SMCs, while a sparse coverage of SMCs is acquired by lymphatic
vessels only after valve formation and concomitant remodeling of a
primitive vascular plexus to mature collecting vessels (Oliver and
Srinivasan, 2008). In line with the abnormal recruitment of SMCs,
presumptive collecting vessels in Tie1-cko mice demonstrated sig-
niﬁcantly increased expression of endoglin, a co-receptor for mem-
bers of TGF-β superfamily, which has been implicated in the
recruitment of SMCs to blood vessels (Li et al., 1999). Interestingly,
increased expression of endoglin has been reported in Pik3r1 null
mice (Mouta-Bellum et al., 2009), and as discussed below, PI3K is a
downstream target of the Tie1/Tie2 signaling pathway. Recent
studies using endoglin transgenic mice indicated that endoglin over-
expression in vascular precursor cells promoted vascular smooth
muscle cell investment of major vessels (Mancini et al., 2007).
Blood-ﬁlled mesenteric lymphatics and bloody superﬁcial intest-
inal lymphatics were often observed in Tie1-cko mice from 3 days of
age. We conﬁrmed that these bloody vessels were lymphatics rather
than blood vessels by whole-mount Lyve1 staining (Fig. 3D and data
not shown). This phenotype shares similarity with Cx37x3Cx43x4
double knockout mice (Kanady et al., 2011), which also demonstrated
lymphatic valve defects. However, in that model blood in the
lymphatic system was observed much earlier (from late embryo
stage E18.5). A similar observation of blood ﬁlled lymphatics was
observed in the slp-76 null mice and was attributed to nonseparation
of the venous and lymphatic circulations (Abtahian et al., 2003). As
described by Srinivasan and Oliver (2011) and Turner et al. (2014),
the lymphatic vessels communicate with the blood vessels only at
the junction of the jugular and subclavian veins and the embryonic
lymphovenous valves control this vital communication from E13.5.
They are formed by the intercalation of LECs with a subpopulation of
venous ECs at the junction of the jugular and subclavian veins. We
observed normal lymphovenous valve formation and lymphatic-
blood vessel separation in Tie1-cko embryos. In addition, we saw
no evidence of aberrant connections between lymphatic vessels and
blood vessels of Tie1-cko neonates. Blood vessels of the mesenteries
in the Tie1-cko mice looked normal (data not shown) and tissue
hemorrhage was not a source of red blood cells in the lymphatics.
Thus, a nonseparation phenotype in Tie1-cko mice was unlikely to be
the etiology of retrograde ﬂow of venous blood to entering the
lymphatic vasculature but is likely a compound effect of lymphatic
valve deﬁciencies and subsequent heart failure in postnatal animals.
Tie1 cko mice display phenotypic similarity to Ang2 null mice
The Tie1-deﬁcient mice in this study share many features with the
Ang2 null mice that have been shown to have abnormal lymphatic
vessel architecture, defective remodeling, ectopic SMC coverage, and
valve agenesis (Dellinger et al., 2008; Gale et al., 2002). Recently,
Ang2 had been reported to be indispensable before and during
lymphatic valve morphogenesis (Zheng et al., 2014). Ang2 is a known
ligand for Tie2, another endothelial receptor tyrosine kinase which
often serves as an antagonist of Tie2 activity during angiogenesis but
as an agonist during lymphangiogenesis (Gale et al., 2002). The
similarity in defects observed between the Ang2 null mice and Tie1-
cko mice raises the possibility of interactions between Tie1 and Tie2
signaling during lymphatic valve development. Tie1 shares a high
degree of homology and is able to form heterodimers with Tie2
(Marron et al., 2000; Peters et al., 2004; Yancopoulos et al., 2000).
The Tie receptors are co-expressed in both blood vascular and
lymphatic ECs. In fact, to date no EC population has been described
to only express Tie1 or Tie2. Increasing, evidences suggest that Tie1
can play a role as an inhibitory coreceptor for Tie2 since Tie1 and Tie2
appear to associate on the cell surface and Tie1 also attenuates Ang1
activation or Ang2 inhibition of Tie2 activation (Marron et al., 2007;
Seegar et al., 2010). Therefore, Tie1 might modulate Ang2 function
via the Tie2 receptor in the developing valvular LECs in vivo as has
documented by in vitro studies utilizing mature lymphatic endothe-
lial cells (Song et al., 2012). The absolute requirement for Tie1 and
Tie2 during angiogenic remodeling and vessel maintenance suggests
that a well-balanced Tie2/Tie1 ratio is critical to the development of
new vessels and the regression of existing vessels (Augustin et al.,
2009). Interestingly, Tie2 is highly expressed in venous valves,
starting from the earliest developmental stages (Bazigou et al.,
2011) and experiments using cultured endothelial monolayers
in vitro also revealed that Tie2 was upregulated and activated upon
exposure of cells to shear stress (Chlench et al., 2007; Lee and Koh,
2003). Thus, it is tempting to speculate that Tie2, in concert with Tie1
serves as a shear stress mediator involved in initiating lymphatic
valve formation. In support of this possibility, Tie1 deletion in the
systemic vasculature in regions of disturbed ﬂow results in an
increase in Tie2 activation without increase in Tie2 expression
(Woo et al., 2011).
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Tie1 is capable of activating both PI3K and Akt to promote end-
othelial survival (Kontos et al., 2002; Yuan et al., 2007) and signaling
through PI3K and Akt is essential for Ang1/Tie2-induced endothelial
survival, sprouting, migration and capillary tube formation (Fukuhara
et al., 2008; Saharinen et al., 2008). It is interesting to note that both
PI3K and Akt are required for valve morphogenesis. Pik3r1 null mice
lacking the regulatory isoforms of the class Ia PI3K, p85α/p55α/p50α,
died by P1 and showed severe lymphatic defects including defective
lymphatic vessel remodeling, and lack of valves (Mouta-Bellum et al.,
2009). The newborn mice with a point mutation abrogating the
interaction between p110α (a catalytic subunit of PI3K) and Ras were
also reported to display chylous ascites and defective lymphatic
development (Gupta et al., 2007). In addition, lack of Akt1 leads to
more speciﬁc defects in the formation of lymphatic valves in the
superﬁcial collecting vessels of the skin (Zhou et al., 2010). The
phenotype observed in the Tie1-cko mice described here are consis-
tent with perturbation in the PI3K and Akt pathways resulting from
either Tie1 deletion alone and/or loss of Tie1 attenuation of Tie2
activation. Thus, we propose that Tie signaling is an important
component of the mechanosensors of shear stress in endothelial cells
contributing to initiate the Prox1high Foxc2 high LEC clusters and
establish the valve territory via the activation of calcineurin/Nfatc1,
thus triggering subsequent steps of lymphatic valve development:
valve leaﬂet formation, maturation and sinus formation (Fig. 9). In the
disruption of Tie1/Tie2 signaling (as Tie1/PI3K/Akt mutants), lymphatic
valve-forming cells fail to form Prox1high Foxc2 high LEC clusters and
assemble the ring-like valve territory, resulting lack of valves.
Conclusions
Our ﬁndings identify Tie1 as a critical regulator of lymphatic
vessel remodeling and maturation as well as valve morphogenesis.
Our study also sheds light on early steps of lymphatic valve mor-
phogenesis, and suggests that Tie signaling is an important compo-
nent for mechanosensing of shear stress in lymphatic endothelial
cells maintaining the critical and patterned high expression of Prox1
and Foxc2 in prospective valve-forming cells. Future studies, includ-
ing the functional knockdown of Tie2 in primary lymphatic endothe-
lial cells during development as well as in the postanatal period,
should help to identify the direct target genes of Ang-Tie system and
enhance understanding of the mechanisms regulating lymphatic
remodeling and maturation, and the formation of luminal valves.
This work should help in elucidating basic mechanisms underlying
genetic defects in lymphatic development as well inform potential
therapies to accelerate post-surgical lymphatic repair.
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